NCT04614714View on ClinicalTrials.gov

Milk Volume Outcomes Following Oral Nicotinamide Riboside Supplementation in Mothers of Extremely Preterm Infants

PHASE2/PHASE3RecruitingINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

December 1, 2024

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2027

Conditions
Preterm BirthInadequate Milk Production
Interventions
DRUG

Nicotinamide riboside chloride

Nicotinamide riboside chloride 250 mg capsules, administered once per day (Day 1-7 or Day 11-17)

DRUG

Placebo

Maltodextrin placebo, administered once per day (Day 1-7 or Day 11-17)

Trial Locations (1)

95817

RECRUITING

UC Davis Department of Food Science and Technology, Sacramento

All Listed Sponsors
lead

University of California, Davis

OTHER